Terms: = Sarcomas AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
14 results:
1. Mesenchymal neoplasms of the parotid gland and parapharyngeal space: an FNA cytologic study of 22 nonlipomatous tumors.
Wakely PE
Cancer Cytopathol; 2022 Jun; 130(6):443-454. PubMed ID: 35195952
[TBL] [Abstract] [Full Text] [Related]
2. clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue sarcomas.
O'Sullivan Coyne G; Kummar S; Hu J; Ganjoo K; Chow WA; Do KT; Zlott J; Bruns A; Rubinstein L; Foster JC; Juwara L; Meehan R; Piekarz R; Streicher H; Sharon E; Takebe N; Voth AR; Bottaro D; Costello R; Wright JJ; Doroshow JH; Chen AP
Clin Cancer Res; 2022 Jan; 28(2):279-288. PubMed ID: 34716194
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
[TBL] [Abstract] [Full Text] [Related]
4. clinical, radiological, and pathological features of extraskeletal osteosarcoma.
Roller LA; Chebib I; Bredella MA; Chang CY
Skeletal Radiol; 2018 Sep; 47(9):1213-1220. PubMed ID: 29502131
[TBL] [Abstract] [Full Text] [Related]
5. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
[TBL] [Abstract] [Full Text] [Related]
6. Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer.
Henneman L; van Miltenburg MH; Michalak EM; Braumuller TM; Jaspers JE; Drenth AP; de Korte-Grimmerink R; Gogola E; Szuhai K; Schlicker A; Bin Ali R; Pritchard C; Huijbers IJ; Berns A; Rottenberg S; Jonkers J
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8409-14. PubMed ID: 26100884
[TBL] [Abstract] [Full Text] [Related]
7. Langerhans cell sarcoma: a systematic review.
Howard JE; Dwivedi RC; Masterson L; Jani P
Cancer Treat Rev; 2015 Apr; 41(4):320-31. PubMed ID: 25805533
[TBL] [Abstract] [Full Text] [Related]
8. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
[TBL] [Abstract] [Full Text] [Related]
9. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
[TBL] [Abstract] [Full Text] [Related]
10. A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study.
McMeekin DS; Sill MW; Darcy KM; Abulafia O; Hanjani P; Pearl ML; Rubin SC; Rose PG; Small L; Benbrook DM
Gynecol Oncol; 2012 Nov; 127(2):356-61. PubMed ID: 22796461
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract] [Full Text] [Related]
12. Synovial sarcoma (SS): new perspectives supported by modern technology.
Llombart-Bosch A; Lopez-Guerrero JA; Peydro-Olaya A
Arkh Patol; 2002; 64(3):39-47. PubMed ID: 15338724
[TBL] [Abstract] [Full Text] [Related]
13. Potent and selective inhibitors of the met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
Wang X; Le P; Liang C; Chan J; Kiewlich D; Miller T; Harris D; Sun L; Rice A; Vasile S; Blake RA; Howlett AR; Patel N; McMahon G; Lipson KE
Mol Cancer Ther; 2003 Nov; 2(11):1085-92. PubMed ID: 14617781
[TBL] [Abstract] [Full Text] [Related]
14. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract] [Full Text] [Related]